NCT06512662

Brief Summary

Cancers of the upper respiratory / digestive tract are a major public health problem, ranking 5th among the most common cancers. Surgery plays a central role in the recommended treatments for this type of pathology. The surgical procedure and its after-effects can be anxiety-provoking and have a major psychological, physical and social impact on patients over the long term. Our institution's standard protocol is based on a pre-operative supportive care day hospital. The aim of this study is to compare our current care pathway with a more extensive interdisciplinary care pathway focused on patients' needs, in order to reduce anxiety and improve the quality of life of patients undergoing surgery for cancers of the upper respiratory / digestive tract. Our aim is to use a prospective single-centre interventional study to assess the impact of adding three post-operative day hospitals to the existing care pathway in terms of reducing anxiety and improving the quality of life of patients undergoing surgery.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 16, 2024

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 22, 2024

Completed
3 months until next milestone

Study Start

First participant enrolled

October 8, 2024

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2026

Completed
Last Updated

October 10, 2024

Status Verified

October 1, 2024

Enrollment Period

1.1 years

First QC Date

July 16, 2024

Last Update Submit

October 8, 2024

Conditions

Keywords

surgeryquality of lifeanxietysupportive care

Outcome Measures

Primary Outcomes (1)

  • Anxiety

    Anxiety evaluation by State Trait Anxiety Inventory (STAI) scale. It is a psychological inventory consisting of 40 self-report items on a 4-point Likert scale. The STAI measures two types of anxiety - state anxiety and trait anxiety. Higher scores are positively correlated with higher levels of anxiety.

    1 month ; 3 months ; 6 months

Secondary Outcomes (7)

  • Quality of life evaluation

    1 month ; 3 months ; 6 months

  • pain evaluation

    1 month ; 3 months ; 6 months

  • Toxic behaviour (tobacco and alcohol) evaluation

    1 month ; 3 months ; 6 months

  • Weight status evaluation

    1 month ; 3 months ; 6 months

  • nutritional status evaluation

    1 month ; 3 months ; 6 months

  • +2 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Supportive care

EXPERIMENTAL
Procedure: Consultations with paramedics

Interventions

Patients of experimental arm will beneficiate of supplemental consultations with paramedics intervenants at 1 month, 3 months and 6 months after surgery : * dietetician * speech therapist * psychologist * advanced practice nurse During these consultations, several scales will be performed to assess the patient's condition (anxiety, nutritional status, psychological condition, speech therapy status).

Supportive care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation
  • Understanding of spoken and written French
  • Patient covered by a social security scheme

You may not qualify if:

  • Protected patient under a protective measure or legal safeguard
  • Pregnant or breast-feeding patients
  • Patients suffering from major cognitive disorders
  • Patients with major anxiety disorders prior to the onset of cancer

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinique Pasteur Lanroze

Brest, 29000, France

RECRUITING

MeSH Terms

Conditions

Otorhinolaryngologic NeoplasmsAnxiety Disorders

Interventions

Referral and ConsultationParamedics

Condition Hierarchy (Ancestors)

Head and Neck NeoplasmsNeoplasms by SiteNeoplasmsOtorhinolaryngologic DiseasesMental Disorders

Intervention Hierarchy (Ancestors)

Professional PracticeOrganization and AdministrationHealth Services AdministrationAllied Health PersonnelHealth PersonnelHealth Care Facilities Workforce and Services

Central Study Contacts

Camille Vuarin, APN

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 16, 2024

First Posted

July 22, 2024

Study Start

October 8, 2024

Primary Completion

October 31, 2025

Study Completion

March 31, 2026

Last Updated

October 10, 2024

Record last verified: 2024-10

Data Sharing

IPD Sharing
Will not share

Locations